|
General Information
|
|
|
Product
|
SARS-CoV-2 ORF7a Peptide
|
|
Description
|
Antigenic Blocking Peptide ORF7a protein [Severe acute respiratory syndrome coronavirus 2] Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Species Cross Reactivity
|
Virus
|
|
Peptide Description
|
Synthetic peptide taken from unique amino acid sequence on ORF7a [Severe acute respiratory syndrome coronavirus 2].
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Alternative Nomenclature
|
ORF7A Protein
Severe acute respiratory syndrome Coronavirus 2
WUHAN-ORF7A
|
|
|
|
SARS-CoV-2 ORF7a Antibody
SARS-CoV-2 ORF7a Antibody BIOTIN
SARS-CoV-2 ORF7a Antibody FITC
SARS-CoV-2 ORF7a Positive Control
